title: [cis-Dichlorodiammine platinum (II) in the treatment of advanced colo-rectal cancer].
abstract: The effect of CDDP was evaluated in 10 cases of advanced colo-rectal cancer. Prior chemotherapy was done in seven cases and three were fresh cases. The dosage of CDDP was in the range of 70-100 mg/m2 per individual. Seven cases out of 10 receiving the CDDP chemotherapy achieved no change and there were three cases of PD. Response rate was 0%. Values of serum creatinine and BUN were transiently evaluated and bone marrow toxicity was moderate. Emesis of patients treated with CDDP was suppressed by the administration of high doses of metoclopramide (2 mg/kg X 4 times).
authors.forename: H
authors.initials: H
authors.lastname: Dozono
authors.forename: Y
authors.initials: Y
authors.lastname: Moriya
authors.forename: N
authors.initials: N
authors.lastname: Saijo
authors.forename: J
authors.initials: J
authors.lastname: Fujita
authors.forename: Y
authors.initials: Y
authors.lastname: Koyama
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D002288:Adenocarcinoma, Mucinous / Q000188:drug therapy*; D000328:Adult; D002945:Cisplatin / Q000627:therapeutic use*; D003110:Colonic Neoplasms / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012004:Rectal Neoplasms / Q000188:drug therapy*
chemical_list: D002945:Cisplatin